Get informed when a big investor buys or sells
+ FollowOvervalued by 98.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $21.17 Million |
|---|---|
| Enterprise Value | $19.39 Million |
| Earnings per Share | $-0.02 |
| Beta | 0.29 |
| Outstanding Shares | 223,795,260 |
| P/E Ratio | -7.1 |
|---|---|
| PEG | 21.87 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 380.03 |
| Enterprise Value to EBIT | -6.12 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based active pharmaceutical ingredients (APIs). The company aims to produce radiocontrast agents utilizing barium and iodine, along with pharmaceutical products derived...